BioSpace News Archive

Telix Pharmaceuticals Limited announces that its prostate cancer imaging agent, Illuccix®, also known as 68Ga-PSMA-11 injection, is now commercially available in the United States.

Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure patients, announced results of a clinical study demonstrating the efficacy of its contact-free technology for the detection of pulmonary congestion at home.

ReAlta Life Sciences today announced first-in-human Phase 1 clinical data on RLS-0071, the Company’s complement inhibitor and innate anti-inflammatory product candidate.

A new trace-level silica analyzer for real-time monitoring of ultrapure water, steam and water chemistry can more accurately protect expensive components, including turbines and heat exchangers.

AmerisourceBergen & Good Neighbor Pharmacy Surpass 5 Million Vaccine Doses Allocated through its Federal Retail Pharmacy Program for COVID-19 Vaccination.

NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multi-omics, was invited to present a poster at the prestigious annual meeting of the American Association of Cancer Research (AACR) meeting on April 13th, 2022.

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced a collaboration with IRIS (Intelligent Retinal Imaging Systems) to deliver diabetic retinal imaging services through designated Quest Diagnostics patient service centers across the United States to aid in screening patients for retinal assessment by a healthcare provider.

FEops announced that it received authorization from the U.S. Food and Drug Administration for FEops HEARTguide™ pre-operative planning of left atrial appendage occlusion with the Abbott’s Amplatzer™ Amulet™ and Boston Scientific’s Watchman FLX™ device*.

Altamira Therapeutics Ltd., a company dedicated to developing therapeutics that address important unmet medical needs, announced it will hold an investor call on Tuesday, April 12, 2022, 8:00 a.m. ET to discuss its full-year 2021 earnings.

Royal Philips, a global leader in health technology, announced late-breaking results of a large-scale, real-world analysis of U.S. Centers for Medicare & Medicaid Services data on the rates of guideline adherence and associated mortality in patients with CIED infection.